Chairmans address 22/11/2018
Twelve months ago, the Board set itself three key milestone targets to achieve in 2018, and I am very pleased to report that all three have been achieved this year. These are:
1. Receiving the full GMP certification and manufacturing license of our European Medical Cannabis Manufacturing Facility;
2. Gaining St Vincent’s Ethics Committee and then TGA Approval for authorised prescribers of CannEpilTM in Australia; and
3. Securing a licence to build and operate a commercial scale medical cannabis facility in Europe for the production of GMP flowers and GMP pharma grade medicine.
Malta?
Malta timelines. What does it all mean?, page-15
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.025(9.26%) |
Mkt cap ! $14.27M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 29.5¢ | 27.0¢ | $2.947K | 10.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 8174 | 2 |
View Market Depth
| Last trade - 13.16pm 07/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |